SINGAPORE, Jan. 31, 2012 /PRNewswire-Asia/ -- Boston Scientific
Corporation (NYSE: BSX) announces the creation of its Asia-Pacific
regional organization that includes Australia, New Zealand, China,
Hong Kong, India, Japan, South Korea, South East Asia, Taiwan and
Turkey. The Company believes this pan-Asia business model will help
drive growth by leveraging best practices in the region, accessing
the strong pool of local talent, and collaborating with healthcare
professionals and regulatory agencies throughout the region.
"During the past year, we have laid a solid foundation for
consistent growth in the key emerging markets of China and India.
Our strategic investments in these countries have already begun to
generate results and expand our regional footprint," said Hank
Kucheman, Chief Executive Officer of Boston Scientific. "We will
now work to leverage these results to streamline our organization
and strengthen our market position across Asia, the world's fastest
growing region, by creating Boston Scientific Asia-Pacific."
The organization will be led by Supratim Bose, Executive Vice
President and President, Asia-Pacific for Boston Scientific. Before
joining Boston Scientific in January 2012, Mr. Bose was Founder and
Chief Executive Officer of Singapore-based Bose Consulting Group,
which specialized in strategic management consulting services for
the healthcare industry. Previously, he worked for nearly 30 years
at Johnson & Johnson, where he concluded his tenure as the
Company Group Chairman of its Medical Devices and Diagnostics
(MD&D) business in 2009. In this role, he managed Johnson &
Johnson's MD&D companies throughout Asia-Pacific, including
Japan, having pioneered its entry in all emerging markets in Asia,
including China, India and Vietnam.
"I am honored to take on a leadership role in this newly created
organization for such a well-recognized company and leader in the
medical device industry," said Bose. "Our mission is to serve more
patients in every market in this region. We have an incredible
opportunity for growth, and I am excited to lead this team in
establishing a greater presence for Boston Scientific in
Asia-Pacific."
"Last year, Boston Scientific announced its plan to invest $150
million in China to build a facility for medical device
manufacturing and healthcare provider training. Additional
significant investments in India and other key markets in the
region are planned," added Bose. "A major emphasis for growth will
be in our drug-eluting stent (DES) business where our current
market share in much of Asia-Pacific is far eclipsed by the
Company's DES share in the U.S. and worldwide. We anticipate
numerous planned product launches in the region in 2012, including
the platinum chromium PROMUS Element(TM) Stent platform, which is
expected to launch in Japan by mid-year."
About Boston Scientific Boston Scientific is a worldwide developer,
manufacturer and marketer of medical devices that are used in a
broad range of interventional medical specialties. For more
information, please visit: www.bostonscientific.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements. Boston
Scientific wishes to caution the reader of this press release that
actual results may differ from those discussed in the
forward-looking statements and may be adversely affected by, among
other things, risks associated with organizational structure,
management transition plans, our market share, growth and business
strategy, potential investments, product launch plans, and other
factors described in Boston Scientific's filings with the
Securities and Exchange Commission.
CONTACTS:
Australia/New Zealand
Mark Wallwork Managing Director
+61-2-8063-8131 [email protected]
China/Hong Kong
Rob Sandfelder VP, China/Hong Kong
+862161415925 [email protected]
India
Bob Neidermire Country Director, India
+91-124-492-3300 [email protected]
Korea
Oh Kyung Yul Country Director, Korea
+82-2-3483-1700 [email protected]
South East Asia & Taiwan
Daphne Wang Country Director, South East Asia & Taiwan
+886-2-2652-8133 [email protected]
SOURCE﹛Boston Scientific Corporation